Research article · 29 Dec 2025
CommentaryPublished 29 Apr 2025
Goserelin: Broad Clinical Applications and Benefits
Department of Precision Diagnostics, Starlight Oncology Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Goserelin acetate is a critical therapeutic agent in hormone-sensitive cancers and gynecological conditions. In early breast cancer, it significantly improves disease-free survival and reduces relapse when combined with adjuvant endocrine therapy or neoadjuvant chemotherapy. It offers ovarian protection for young cancer patients and is effective for endometrial ablation, myomectomy, and endometrial polyps. Goserelin also plays a key role in prostate cancer management. These findings collectively establish goserelin as a versatile and impactful treatment, enhancing patient outcomes across a spectrum of clinical applications with a favorable safety profile.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Insights in Gynecologic Oncology.
Rapid communication · 29 Dec 2025
Gynecologic Cancer Screening: Advancements for Early Detection
Rapid communication · 29 Dec 2025
PI3K Pathway: Targeting Ovarian Cancer Therapeutics
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInsights in Gynecologic Oncology
- SubjectOncology & Cancer
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Sophia N. Lee”